Shopping Cart
- Remove All
- Your shopping cart is currently empty
Gunagratinib (ICP-192) is a potent, selective, and orally active pan-FGFR (fibroblast growth factor receptors) inhibitor with low toxicity, demonstrating irreversible covalent binding to effectively inhibit FGFR activities, making it particularly suitable for cancer research purposes.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $647 | Backorder |
Description | Gunagratinib (ICP-192) is a potent, selective, and orally active pan-FGFR (fibroblast growth factor receptors) inhibitor with low toxicity, demonstrating irreversible covalent binding to effectively inhibit FGFR activities, making it particularly suitable for cancer research purposes. |
In vitro | Gunagratinib (ICP-192) is an orally administered, low-toxicity pan-FGFR (fibroblast growth factor receptors) inhibitor. It irreversibly and selectively halts FGFR functions through covalent binding, demonstrating potent activity[1]. |
Alias | ICP-192 |
Molecular Weight | 423.473 |
Formula | C22H25N5O4 |
Cas No. | 2211082-53-8 |
Relative Density. | 1.27 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.